Quantification of immunoglobulin G against trypanosoma cruzi in individuals with chronic chagas disease treated with nifurtimox and evaluated in prolonged follow-up

5Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

In the indeterminate chronic period of Chagas disease (ChD) the treatment has not been conclusive, because the serological negativization requires many years. This study aims to evaluate the efficacy of nifurtimox (NF) in the treatment of chronic ChD in prolonged follow-up by serological techniques of indirect immunofluorescence assay (IFA) and enzyme-linked immunosorbent assay (ELISA) IgG comparing 2 groups of patients, treated and non treated. Mann-Whitney test was performed for ELISA and IFA, with significant difference between the groups (P < 0.05). IgG levels were lower in individuals treated compared with untreated patients, indicating chemotherapeutic efficacy in prolonged follow-up.

Cite

CITATION STYLE

APA

Muñoz, G., Vergara, C., Martínez, G., Apt, W., & Zulantay, I. (2019). Quantification of immunoglobulin G against trypanosoma cruzi in individuals with chronic chagas disease treated with nifurtimox and evaluated in prolonged follow-up. Korean Journal of Parasitology, 57(1), 39–42. https://doi.org/10.3347/kjp.2019.57.1.39

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free